The DGCR6 gene helps guide early development by influencing how certain other genes are switched on and off, especially in tissues that form the face, heart, and nervous system. If this gene does not work properly, it may contribute to features linked to changes in the 22q11.2 region, including heart differences, palate problems, immune issues, and learning or behavior differences. This gene is most often discussed as part of a chromosome condition called 22q11.2 deletion syndrome, where the DGCR6 gene is one of several genes often missing together.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to produce proteins, which do much of the cell’s work. Others mainly help determine when certain processes happen, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in LearnHub.
Overview
DGCR6Gene function
What if the gene works
The DGCR6 gene may help guide early development, especially in cells that shape parts of the face, heart, and throat. Its protein likely helps turn other genes on and off at the right time.
Risk
What if the gene does not work
Changes in the DGCR6 gene can range from milder to more severe and may reduce how well cells control nearby developmental gene activity. This may alter early cell signaling and gene regulation without a clearly defined DGCR6 specific condition.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the DGCR6 gene, no DGCR6-specific treatment or management approach is currently established. Research has mainly focused on how the DGCR6 gene may contribute to features linked to the 22q11.2 region, rather than on drug choices or targeted therapy.
Gene function
What if the gene works
The DGCR6 gene is active during early growth, when the body is laying down its basic plan. Knowing what the DGCR6 gene does in the body helps explain how cells keep development organized and on schedule.
DGCR6 helps regulate how other genes are used during early development. This supports the timing and coordination cells need as the body starts to form.
This gene supports orderly tissue and organ development in the embryo. By helping coordinate gene activity at the right time, it contributes to the body's early building plan.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
At the cellular level, how variants influence the DGCR6 gene's function often comes down to changes in gene output, RNA processing, or protein stability. Some variants may slightly lower activity, while more severe variants can greatly reduce or disrupt the gene's usual cellular interactions. This creates a spectrum of loss of function, from mild changes in protein behavior to a more marked drop in normal activity.
How variants are linked to conditions
Current evidence on how variants in the DGCR6 gene are linked to conditions is still developing, and this gene does not yet have a broadly confirmed link to one specific health condition. Anyone with a reported DGCR6 finding should use their clinician’s or genetic counselor’s guidance to interpret it in the context of their own health.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to DGCR6 itself. If DGCR6 is discussed as part of a larger chromosome change, overall risk is usually shaped more by that broader genetic finding than by lifestyle or everyday exposures alone.
Inheritance of DGCR6 variants
There is not yet a broadly confirmed, disease specific Mendelian pattern for how variants of the DGCR6 gene are inherited. In practice, when people ask how variants of the DGCR6 gene are inherited, the answer is that no single autosomal dominant, autosomal recessive, or X linked pattern is firmly established for this gene on its own. The DGCR6 gene is located on chromosome 22, which is an autosome, so you inherit one copy from each parent.
What does my DGCR6 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for DGCR6, though this can change as research develops. If you have a specific DGCR6 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Variants in the DGCR6 gene are found with genetic testing for DGCR6 variants, usually using a blood or saliva sample. A lab reads the DNA sequence to look for small changes and may also use chromosome microarray to detect larger missing or extra pieces of chromosome 22 that can include the DGCR6 gene.
When should I consider getting a genetic test?
There is not yet a broadly established reason to have genetic testing just for the DGCR6 gene. Testing decisions are usually based on your symptoms, family history, or a broader test that looks for a small missing or extra piece of chromosome 22, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, although how much it explains depends on the condition and on the type of variant involved. How the body works over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker in another, or causes more side effects in someone else. Differences in how the body absorbs, breaks down, and responds to a drug are common, and they can influence both how well a medicine works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medication. It studies gene and drug patterns to clarify why the same treatment may work differently from one person to another. With many medicines, genes affect both how powerfully a drug works and how the body handles it. This information can support more informed, more individualized treatment choices. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the DGCR6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how medicines work, so questions about treatment, side effects, or medication changes are best discussed with your doctor.
History
DGCR6 was identified during the intense search to map the chromosome 22q11.2 region linked to DiGeorge syndrome, now more often called 22q11.2 deletion syndrome. Initially understood only through visible traits, later recognized as tied to a specific gene, DGCR6 became part of the group of genes studied within the “DiGeorge critical region.” From these first observations, research expanded steadily as scientists refined the boundaries of the deleted segment and named genes located there. In the 1990s and early 2000s, DGCR6 appeared regularly in studies of this region as genetic mapping methods improved. Its history is closely tied to the broader effort to understand how small chromosome losses can shape health and development.